Mylotarg 4.5Mg Injection

₹ 0.00~~₹ 0.00~~

Brand: Mylotarg

Generic: Gemtuzumab Ozogamicin

Manufacturer: Pfizer

Drug class: CD33-directed antibody-drug conjugate (ADC).

Tags:

Description

Introduction to Mylotarg 4.5mg Injection

Mylotarg 4.5mg Injection is a prescription medicine used to treat certain types of acute myeloid leukemia (AML). It contains gemtuzumab ozogamicin, a targeted cancer medicine that works by helping destroy certain leukemia cells.

Mylotarg 4.5mg Injection is given through an intravenous (IV) infusion by a qualified healthcare professional. The dose and treatment schedule depend on the patient’s condition and the doctor’s treatment plan.

Like other cancer medicines, Mylotarg may cause side effects. Patients should use this medicine only under the supervision of their doctor and report any unusual or serious symptoms during treatment.

Uses of Mylotarg 4.5mg Injection

Mylotarg 4.5mg Injection is a prescription medicine used to treat certain types of acute myeloid leukemia (AML). It contains gemtuzumab ozogamicin, a targeted cancer medicine.

Mylotarg is mainly used for patients with CD33-positive AML. It may be given alone or together with other chemotherapy medicines, depending on the patient’s condition and treatment plan.

The medicine works by targeting CD33 proteins found on certain leukemia cells. This helps deliver the medicine directly to these abnormal cells and can help destroy them.

Mylotarg 4.5mg Injection should only be given by a qualified healthcare professional under the supervision of an experienced doctor. The dose and treatment schedule depend on the patient’s age, medical condition, type of AML, and other medicines being used.

Important: Mylotarg is a strong anticancer medicine and should be used only when prescribed by a doctor. Do not use it without proper medical advice.

Storage

Store Mylotarg 4.5mg Injection in a refrigerator at 2°C to 8°C.
Keep the medicine in its original package to protect it from light.
Do not freeze Mylotarg 4.5mg Injection.
Keep it out of the reach of children and pets.
Do not use the injection after the expiry date printed on the package.
The prepared or diluted solution should be stored and used according to the instructions provided by your doctor or pharmacist.

Mylotarg 4.5mg Injection should be stored and handled properly to maintain its quality and effectiveness. Do not use the medicine if the vial appears damaged or if there are any concerns about its storage.

Safety Advice for Mylotarg 4.5mg Injection

Mylotarg 4.5mg Injection contains gemtuzumab ozogamicin and is used to treat certain types of acute myeloid leukemia (AML). It should only be given by a qualified healthcare professional under medical supervision.

Liver problems: Mylotarg can cause serious liver damage, including veno-occlusive disease (VOD). Tell your doctor if you develop abdominal swelling or pain, sudden weight gain, or yellowing of the skin or eyes.
Infusion reactions: Allergic or infusion-related reactions can occur. Patients are usually given preventive medicines before the infusion and monitored during and for at least 1 hour afterward.
Bleeding: Mylotarg may increase the risk of serious bleeding. Report unusual bruising, bleeding, blood in urine or stool, or persistent bleeding to your doctor.
Infections: Treatment may lower blood cell counts and increase the risk of infection. Contact your doctor if you develop fever, chills, or other signs of infection.
Pregnancy: Mylotarg may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and discuss pregnancy plans with their doctor.
Breastfeeding: Breastfeeding is not recommended during treatment with Mylotarg.
Medical monitoring: Your doctor may regularly monitor your liver function, blood counts, and other health parameters during treatment.
Allergy: Do not use Mylotarg if you have previously had a serious allergic reaction to gemtuzumab ozogamicin or any of its ingredients.

How to Use Mylotarg 4.5mg Injection

Mylotarg 4.5mg Injection contains gemtuzumab ozogamicin and is used to treat certain types of acute myeloid leukemia (AML). It is a hospital-administered cancer medicine and should not be self-administered.

Mylotarg is given by intravenous (IV) infusion by a qualified healthcare professional.
Before the infusion, your doctor may give medicines such as acetaminophen, an antihistamine, and a corticosteroid to help reduce infusion-related reactions.
The medicine is prepared by reconstituting the vial and then diluting it before administration.
The diluted Mylotarg solution is generally infused over about 2 hours using an appropriate in-line filter.
The exact dose and treatment schedule depend on the patient’s age, body surface area, type of AML, and treatment regimen.
Patients are monitored during and after the infusion for possible infusion-related reactions and other treatment-related complications.

Side Effects of Mylotarg 4.5mg Injection

Mylotarg 4.5mg Injection contains gemtuzumab ozogamicin and is used to treat certain types of acute myeloid leukemia (AML). Like other cancer medicines, Mylotarg may cause side effects, although not everyone experiences them.

Common Side Effects

Some common side effects may include:

Bleeding
Infection
Fever
Nausea
Vomiting
Constipation
Headache
Skin rash
Loss of appetite
Mouth sores or inflammation (mucositis)
Low white blood cell count with fever (febrile neutropenia)
Increased liver enzymes

These side effects may vary depending on the patient’s condition and other cancer treatments being given with Mylotarg.

Serious Side Effects

Mylotarg can cause serious side effects that require medical attention. These include:

Liver problems: Mylotarg can cause serious liver injury, including hepatic veno-occlusive disease (VOD), which can sometimes be life-threatening.
Severe bleeding: Mylotarg may increase the risk of serious or potentially fatal bleeding.
Serious infections: Treatment can increase the risk of infections.
Infusion-related reactions: Fever, chills, breathing problems, low blood pressure, or allergic reactions may occur during or shortly after the infusion.

When to Contact Your Doctor

Contact your doctor immediately if you experience unusual bleeding, severe abdominal swelling or pain, yellowing of the skin or eyes, difficulty breathing, severe fever, chills, or other unusual symptoms during treatment.

Mylotarg 4.5mg Injection should be administered by a qualified healthcare professional. Do not stop or change your treatment without consulting your doctor.

Note: This information is for educational purposes only and does not replace medical advice from your doctor.